Vivos Inc. (RDGL)
| Previous Close | 0.1598 |
| Open | 0.1598 |
| Bid | 0.1400 x 0 |
| Ask | 0.1470 x 0 |
| Day's Range | 0.1375 - 0.1600 |
| 52 Week Range | 0.0412 - 0.2550 |
| Volume | |
| Avg. Volume | 1,259,054 |
| Market Cap | 62.635M |
| Beta (5Y Monthly) | 1.03 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings Date | Nov 04, 2024 - Nov 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireVivos Inc. Certifies New Clinic for IsoPet® Precision Radionuclide TherapyTM
Richland WA N, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. Certifies new clinic for IsoPet therapy. NorthStar Vets - Veterinary Emergency & Trauma Specialty Center in Robbinsville, NJ. provides 24/7/365 emergency, trauma, and critical care and a suite of veterinary specialty services for small animals. They have been approved and licensed to offer IsoPet Precision Radionuclide Therapy as a cancer treatment for small animals. Dr. Korenko stated “An important objective i
- GlobeNewswire
Vivos Inc. Extended its IsoPet® Precision Radionuclide TherapyTM to Exotics
Richland WA N, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. We recently treated our first exotic animal, a ferret, with encouraging results, seeing a considerable reduction in tumor size after three weeks. Treatment options for cancer in small exotic animals remain limited, and the current standard of care—surgical tumor removal—can be too invasive for exotic animals. Dr. Korenko commented, “While we have experience treating cats, dogs, and horses, there is a growing n
